Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses
AssigneeDupont Nutrition Biosciences Aps
InventorsSEBASTIEN GUERY, MARKUS LEHTINEN, SINIKKA ANNELI LATVALA, LIISA LEHTORANTA, BRYAN-JAMES Zabel, WESLEY WILLIAM MOROVIC, CHARLES BUDINOFF, SCOTT D. POWER
Life of this patent
Estimating the term…
Abstract
This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.
Claims18
A method of treating illness and/or symptoms associated with coronaviruses in a subject in need thereof, said method comprising administering an effective amount of a composition comprising Bifidobacterium longum subsp. infantis strain Bi-26;
- Bifidobacterium animalis subsp. lactis strain Bl-04;
- Lacticaseibacillus paracasei strain Lpc-37;
- Lacticaseibacillus rhamnosus strain Lr-32 and Ligilactobacillus salivarius strain Ls-33 to said subject, wherein the coronavirus is selected from the group consisting of 229E (alpha coronavirus), NL63 (alpha coronavirus), OC43 (beta coronavirus), HKU1 (beta coronavirus), MERS-CoV (Middle East Respiratory Syndrome coronavirus), SARS-CoV, and SARS-CoV-2 virus.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
12-14. (canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.